ENDRA Life Sciences Inc. — Director's Dealing 2021

Jun 22, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2021-06-18

Reporting Person: Pestrikova Irina (Senior Director, Finance)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.70	2030-10-27	Common Stock (4000)		Direct
Stock Options	$2.23	2031-02-05	Common Stock (4000)		Direct

Footnotes

F1: This stock option grant becomes exercisable with respect to 1,334 shares of common stock on the first anniversary of the grant date and with respect to 1,333 shares of common stock on the second and third anniversary of the grant date.